Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Mitigation and herd immunity strategy for COVID-19 is likely to fail

View ORCID ProfileBarbara Adamik, View ORCID ProfileMarek Bawiec, View ORCID ProfileViktor Bezborodov, View ORCID ProfileWolfgang Bock, View ORCID ProfileMarcin Bodych, View ORCID ProfileJan Pablo Burgard, Thomas Götz, View ORCID ProfileTyll Krueger, View ORCID ProfileAgata Migalska, View ORCID ProfileBarbara Pabjan, View ORCID ProfileTomasz Ożański, View ORCID ProfileEwaryst Rafajłowicz, View ORCID ProfileWojciech Rafajłowicz, View ORCID ProfileEwa Skubalska-Rafajłowicz, Sara Ryfczyńska, View ORCID ProfileEwa Szczurek, View ORCID ProfilePiotr Szymański
doi: https://doi.org/10.1101/2020.03.25.20043109
Barbara Adamik
bWrocław Medical University, Department of Anesthesiology and Intensive Therapy, Poland
aMOCOS International research group,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Barbara Adamik
  • For correspondence: mocos.international@gmail.com
Marek Bawiec
cWrocław University of Science and Technology, Poland
aMOCOS International research group,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marek Bawiec
  • For correspondence: mocos.international@gmail.com
Viktor Bezborodov
cWrocław University of Science and Technology, Poland
aMOCOS International research group,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Viktor Bezborodov
  • For correspondence: mocos.international@gmail.com
Wolfgang Bock
dTechnische Universität Kaiserslautern, Technomathematics group, Kaiserslautern, Germany
aMOCOS International research group,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Wolfgang Bock
  • For correspondence: bock@mathematik.uni-kl.de mocos.international@gmail.com
Marcin Bodych
cWrocław University of Science and Technology, Poland
aMOCOS International research group,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marcin Bodych
  • For correspondence: mocos.international@gmail.com
Jan Pablo Burgard
eTrier University, Germany
aMOCOS International research group,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jan Pablo Burgard
  • For correspondence: mocos.international@gmail.com
Thomas Götz
fUniversity of Koblenz, Germany
aMOCOS International research group,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mocos.international@gmail.com
Tyll Krueger
cWrocław University of Science and Technology, Poland
aMOCOS International research group,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tyll Krueger
  • For correspondence: mocos.international@gmail.com
Agata Migalska
aMOCOS International research group,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Agata Migalska
  • For correspondence: mocos.international@gmail.com
Barbara Pabjan
gUniversity of Wrocław, Poland
aMOCOS International research group,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Barbara Pabjan
  • For correspondence: mocos.international@gmail.com
Tomasz Ożański
cWrocław University of Science and Technology, Poland
aMOCOS International research group,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tomasz Ożański
  • For correspondence: mocos.international@gmail.com
Ewaryst Rafajłowicz
cWrocław University of Science and Technology, Poland
aMOCOS International research group,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ewaryst Rafajłowicz
  • For correspondence: mocos.international@gmail.com
Wojciech Rafajłowicz
cWrocław University of Science and Technology, Poland
aMOCOS International research group,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Wojciech Rafajłowicz
  • For correspondence: mocos.international@gmail.com
Ewa Skubalska-Rafajłowicz
cWrocław University of Science and Technology, Poland
aMOCOS International research group,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ewa Skubalska-Rafajłowicz
  • For correspondence: mocos.international@gmail.com
Sara Ryfczyńska
cWrocław University of Science and Technology, Poland
aMOCOS International research group,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mocos.international@gmail.com
Ewa Szczurek
hUniversity of Warsaw, Poland
aMOCOS International research group,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ewa Szczurek
  • For correspondence: mocos.international@gmail.com
Piotr Szymański
cWrocław University of Science and Technology, Poland
aMOCOS International research group,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Piotr Szymański
  • For correspondence: mocos.international@gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

On the basis of a semi-realistic SIR microsimulation for Germany and Poland, we show that the R0 parameter interval for which the COVID-19 epidemic stays overcritical but below the capacity limit of the health care system to reach herd immunity is so narrow that a successful implementation of this strategy is likely to fail, which is in contrast to results obtained from classical differential equation models. Our microsimulation is based on official census data and involves household composition and age distribution as the main population structure variables. Outside household contacts are characterised by an out-reproduction number R* which is the only free parameter of the model. For a subcritical domain we compute the time till extinction and prevalence as a function of the initial number of infected individuals and R*. For the Polish city of Wrocław we also discuss the combined impact of testing coverage and contact reduction. For both countries we estimate R* for disease progression until 20th of March 2020.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

We would like to thank the University of Science and Technology Wroclaw, the University of Wroclaw and the Medical University of Wroclaw for their support and assistance to the MOCOS group. We also thank the City of Wroclaw, Nokia Wroclaw, EY GDS Poland and MicroscopeIT for their support.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data we used is either open source or as the census data from the countries we used was provided from the state of Germany and Poland resp.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted May 05, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Mitigation and herd immunity strategy for COVID-19 is likely to fail
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Mitigation and herd immunity strategy for COVID-19 is likely to fail
Barbara Adamik, Marek Bawiec, Viktor Bezborodov, Wolfgang Bock, Marcin Bodych, Jan Pablo Burgard, Thomas Götz, Tyll Krueger, Agata Migalska, Barbara Pabjan, Tomasz Ożański, Ewaryst Rafajłowicz, Wojciech Rafajłowicz, Ewa Skubalska-Rafajłowicz, Sara Ryfczyńska, Ewa Szczurek, Piotr Szymański
medRxiv 2020.03.25.20043109; doi: https://doi.org/10.1101/2020.03.25.20043109
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Mitigation and herd immunity strategy for COVID-19 is likely to fail
Barbara Adamik, Marek Bawiec, Viktor Bezborodov, Wolfgang Bock, Marcin Bodych, Jan Pablo Burgard, Thomas Götz, Tyll Krueger, Agata Migalska, Barbara Pabjan, Tomasz Ożański, Ewaryst Rafajłowicz, Wojciech Rafajłowicz, Ewa Skubalska-Rafajłowicz, Sara Ryfczyńska, Ewa Szczurek, Piotr Szymański
medRxiv 2020.03.25.20043109; doi: https://doi.org/10.1101/2020.03.25.20043109

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1096)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (500)
  • Epidemiology (9767)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2308)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1559)
  • Health Policy (736)
  • Health Systems and Quality Improvement (603)
  • Hematology (236)
  • HIV/AIDS (503)
  • Infectious Diseases (except HIV/AIDS) (11641)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (237)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2142)
  • Nursing (134)
  • Nutrition (336)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (517)
  • Oncology (1176)
  • Ophthalmology (364)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (146)
  • Palliative Medicine (50)
  • Pathology (311)
  • Pediatrics (695)
  • Pharmacology and Therapeutics (300)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2180)
  • Public and Global Health (4657)
  • Radiology and Imaging (778)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (210)
  • Surgery (251)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)